In our study, knockdown of HER2 in pancreatic cancer cells showed an enhanced HER3 protein expression, upregulation of PI3K/ERK/C-Myc pathway and subsequent increase in cell proliferation. The gene discussed is MYC; the disease is familial pancreatic carcinoma.